LEMKEY JOHN G (Chief Financial Officer) received a stock award from ODONATE THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 2/4/2020ACC: 0001209191-20-006354
Officer· Chief Financial Officer
Since Jun 2018
+96.00
Net shares
Net buyer
$1.2K
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
96.00 acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+48.00
Price / share
$24.82
Trade value
$1.19K
% of position
2.1%
1/31/2020
2.27K→2.32K
Total
Net shares
+48.00
Net value
$1.19K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/31/2020 | A · Award | +48.00 | $24.82 | $1.19K | 2.1% | 2.27K | 2.32K |
| Total | +48.00 | $1.19K | ||||||
Derivative Transactions1
Employee Stock Option (Right to Buy)
Direct
Converts to
Common Stock
48.00 shares
Shares
+48.00
Strike price
29.20
Held after
48.00
Exercisable
—
1/31/2020
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy) Direct | Common Stock48.00 shares | 1/31/2020 | A · Award | +48.00 | 29.20 | — | 48.00 |
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned14.08M
Total
14.08M indirect14.08M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 14.08M | Indirect |
| Total | 14.08M | 14.08M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported